Sopharma Buildings ADSITS
Sopharma Buildings ADSITS operates as a diversified real estate investment trust (REIT) in the Real Estate sector, generating revenue primarily through property ownership and management.
Business. Sopharma Buildings ADSITS (BGSFB.BB) is a diversified real estate investment trust that generates revenue primarily through rental income. The company operates within the Real Estate sector, specifically classified under the Diversified REITs industry. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Sopharma Buildings ADSITS (BGSFB.BB) is a diversified real estate investment trust that generates revenue primarily through rental income. The company operates within the Real Estate sector, specifically classified under the Diversified REITs industry. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.
Sopharma Buildings ADSITS exhibits a capital structure with no long-term debt and a current ratio of 2.62, indicating strong short-term liquidity. The company holds cash and equivalents of 1,390,000 BGN, which is a significant portion of its total assets of 11,113,000 BGN. However, the company reported negative operating and net income of -34,000 BGN, and a negative return on equity of -0.47%.
The company's profitability is weak, with a negative return on assets of -0.31% and a gross loss of 1,417,000 BGN. These metrics fall significantly below the typical performance of the Diversified REITs industry, which is expected to maintain positive returns and stable margins.
Sopharma Buildings ADSITS does not disclose segment or geographic revenue breakdowns in the available data, making it difficult to assess revenue concentration or geographic exposure. The absence of such data limits the ability to evaluate the company's diversification and risk profile.
The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance. The absence of a clear growth narrative and the current financial performance suggest a need for further analysis to determine the company's long-term viability.
The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's capital structure is currently free of long-term debt, and there are no signs of near-term dilution pressure. However, the negative operating cash flow of -45,000 BGN raises concerns about the company's ability to sustain operations without external financing.
Recent events and filings do not provide additional insights into the company's operations or strategic direction. The absence of recent disclosures or significant events suggests a lack of material developments that could impact the company's financial position or market perception.
- Sopharma Buildings ADSITS has a strong short-term liquidity position with a current ratio of 2.62 and no long-term debt.
- The company is currently unprofitable, with negative operating and net income and a negative return on equity.
- There is no available data on revenue concentration or geographic exposure, limiting the ability to assess diversification.
- The company's growth trajectory is unclear, and there are no signs of immediate liquidity or dilution risk.
- Recent events and filings do not provide additional insights into the company's operations or strategic direction.
Bull / Bear case
Generated · model-assistedThe company maintains a zero debt-to-equity ratio, significantly outperforming the 0.43 median for diversified REITs.
Cash conversion metrics stand at 1.32, exceeding the 0.82 median benchmark for the diversified REITs cohort.
Dilution and liquidity risks are assessed as low, suggesting stable capital structure and market access conditions.
Operating and net margins of -3.78% place the company in the bottom quartile of the diversified REITs cohort.
The company faces high credit risk, signaling potential difficulties in meeting financial obligations or securing favorable financing.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Sopharma Buildings ADSITS Market data — financials · 2026-05-27